BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 17478359)

  • 21. Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Jun; 54(3):277-84. PubMed ID: 16414216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid receptor expression in endometria from women treated with tamoxifen.
    Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
    Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The study on endometrial estrogen receptor and progesterone receptor isoforms in medical abortion women].
    Zhu LH; Huang LL; Huang HF
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):819-22. PubMed ID: 12895330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid receptor expression and HER-2/neu (c-erbB-2) oncoprotein in the uterus of cats with cystic endometrial hyperplasia-pyometra complex.
    Misirlioglu D; Nak D; Sevimli A; Nak Y; Ozyigit MO; Akkoc A; Cangul IT
    J Vet Med A Physiol Pathol Clin Med; 2006 Jun; 53(5):225-9. PubMed ID: 16737511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps.
    Lieng M; Qvigstad E; Sandvik L; Jørgensen H; Langebrekke A; Istre O
    J Minim Invasive Gynecol; 2007; 14(2):189-94. PubMed ID: 17368255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
    Duffy SR; Taylor L
    Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Balle A; Kriegel S; Kupka MS; Friese K
    Acta Histochem; 2004; 106(3):245-52. PubMed ID: 15186931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of estrogen and progesterone receptors in the endometrium of common marmosets Callithrix jacchus.
    Kholkute SD; Nandedkar TD; Puri CP
    Indian J Exp Biol; 2000 May; 38(5):425-31. PubMed ID: 11272404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.
    Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G
    Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Mar; 53(4):454-61. PubMed ID: 16169691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.
    Reich O; Regauer S; Urdl W; Lahousen M; Winter R
    Br J Cancer; 2000 Mar; 82(5):1030-4. PubMed ID: 10737385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of hormone replacement therapy in endometrial polyp formation.
    Oguz S; Sargin A; Kelekci S; Aytan H; Tapisiz OL; Mollamahmutoglu L
    Maturitas; 2005 Mar; 50(3):231-6. PubMed ID: 15734604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps.
    Taylor LJ; Jackson TL; Reid JG; Duffy SR
    BJOG; 2003 Sep; 110(9):794-8. PubMed ID: 14511960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
    Liao QP; Wu C; Zheng H; Yu L
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women.
    Zang H; Sahlin L; Masironi B; Hirschberg AL
    Menopause; 2008; 15(2):233-9. PubMed ID: 18030175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
    Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
    Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hysteroscopic polypectomy decreases NF-κB1 expression in the mid-secretory endometrium of women with endometrial polyp.
    Bozkurt M; Şahin L; Ulaş M
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():96-100. PubMed ID: 25898371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.